STRUCTURAL AND FUNCTIONAL ANALYSIS OF AF9-MLL ONCOGENIC FUSION PROTEIN USING HOMOLOGY MODELING AND SIMULATION BASED APPROACH

Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2015, Vol 7, Issue 12

Abstract

Objective: AF9-MLL has been implicated in the pathogenesis of AML, New Therapeutic regimens are prerequisite for this category of hematological malignancy due to the poor prognosis. The experimental 3D structure of AF9-MLL is not available. Therefore, present study aims in developing the homology model and evaluating the best model through Energy Minimization and MD simulation. The structure further analyzed for functional Annotation.Methods: To the best of our knowledge, our study is novel in terms of predicting homology based 3D model of AF9-MLL leukemogenic fusion protein, facilitated by I-TASSER. The 3D modeled structure was subsequently optimized with MD simulation for 2 ns. Further stereo-chemical analysis and verification of the best structure so obtained were undertaken by different computational programs including PROCHECK, PROVE, Verify3D and ERRAT.Results: Homology model predicted from I-TASSER and refined by YASARA showed results with 86.5% residues in the most favorable region, 14.7% in the allowed region, 0.8% in the generously allowed region and 0.3% in the disallowed region. The RMSD between the modeled and the refined structure was found to be 2.37 Å. The results of ERRAT, Verify_3D, Prove and ProSA confirmed that the simulated model and energy minimized model is very good then the predicted raw model. The final structure was successfully submitted in Protein Model Database (PMDB) under ID: PM0080061.Conclusion: In this study, homology model was developed and Validated for MLL-AF9 using bio-informatics tools. These analyses validated that the simulated model is best, robust as well as reliable enough to be used for future study and the functional analysis shows the presence of CXXC domain. Eventually, these molecular and structural studies result in advancement of newer therapies. 

Authors and Affiliations

Medha Dave, Aditi Daga, Rakesh Rawal

Keywords

Related Articles

DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE, CILNIDIPINE IN COMBINATION TABLET DOSAGE FORM

Objective: To develop and validate a simple, sensitive and isocratic reverse phase high performance liquid chromatography (RP-HPLC) method for the simultaneous determination of olmesartan medoxomil (OLM), amlodipine besy...

A REVIEW ON THE PHARMACOLOGICAL AND TRADITIONAL PROPERTIES OF MIMOSA PUDICA

Consumption of fruits and vegetables fight against oxidative damage by inhibiting or reducing free radicals and reactive oxygen species. Mimosa pudica is a perennial herb and belongs to the family Fabaceae. Epidemiologic...

SYNTHESIS, CHARACTERIZATION AND ABSORPTION PROPERTIES OF SOME NOVEL HETEROCYCLIC TETRAKISAZO DYES

Objective: The aim of the work was to designed and synthesized novel heterocyclic tetrakisazo dyes.Methods: 2,2'[(4,4'-dihydrazonebiphenyl)]-bis(3-iminobuthyronitrile) (1) were synthesized by diazotization of benzidine u...

NIOSOME-ENCAPSULATED CLOMIPRAMINE FOR TRANSDERMAL CONTROLLED DELIVERY

ABSTRACTClomipramine (CLM) is a highly selective inhibitor of serotonin reuptake antidepressant. The objective of the present research was to decrease the extensive first-pass metabolism of the drug in the liver by devel...

PREVALENCE OF HUMAN PAPILLOMA VIRUS TYPES 16 AND 18 AMONG WOMEN WITH CERVICAL CANCER IN ALEPPO, SYRIA

Objective: Cervical cancer is the second common type of cancer among women worldwide. Infection by certain types of human papillomavirus infection (HPV) such as HPV 16/18 has been considered as the most significant risk...

Download PDF file
  • EP ID EP578049
  • DOI -
  • Views 68
  • Downloads 0

How To Cite

Medha Dave, Aditi Daga, Rakesh Rawal (2015). STRUCTURAL AND FUNCTIONAL ANALYSIS OF AF9-MLL ONCOGENIC FUSION PROTEIN USING HOMOLOGY MODELING AND SIMULATION BASED APPROACH. International Journal of Pharmacy and Pharmaceutical Sciences, 7(12), 155-161. https://europub.co.uk/articles/-A-578049